87
Participants
Start Date
January 31, 2017
Primary Completion Date
April 21, 2023
Study Completion Date
April 25, 2023
Berzosertib
Given IV
Cisplatin
Given IV
Gemcitabine Hydrochloride
Given IV
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
University of Virginia Cancer Center, Charlottesville
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Duke University Medical Center, Durham
Emory University Hospital/Winship Cancer Institute, Atlanta
Vanderbilt Breast Center at One Hundred Oaks, Nashville
Vanderbilt University/Ingram Cancer Center, Nashville
University of Kentucky/Markey Cancer Center, Lexington
Ohio State University Comprehensive Cancer Center, Columbus
Case Western Reserve University, Cleveland
Wayne State University/Karmanos Cancer Institute, Detroit
Weisberg Cancer Treatment Center, Farmington Hills
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Mayo Clinic in Rochester, Rochester
Washington University School of Medicine, St Louis
Siteman Cancer Center-South County, St Louis
Siteman Cancer Center at Christian Hospital, St Louis
Siteman Cancer Center at West County Hospital, Creve Coeur
University of Kansas Clinical Research Center, Fairway
University of Kansas Hospital-Westwood Cancer Center, Westwood
Nebraska Medicine-Village Pointe, Omaha
Nebraska Medicine-Bellevue, Bellevue
University of Nebraska Medical Center, Omaha
UCHealth University of Colorado Hospital, Aurora
Mayo Clinic Hospital in Arizona, Phoenix
Mayo Clinic in Arizona, Scottsdale
Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles
City of Hope Comprehensive Cancer Center, Duarte
Keck Medical Center of USC Pasadena, Pasadena
USC Norris Oncology/Hematology-Newport Beach, Newport Beach
Stanford Cancer Institute Palo Alto, Palo Alto
University of California Davis Comprehensive Cancer Center, Sacramento
Mayo Clinic in Florida, Jacksonville
Massachusetts General Hospital Cancer Center, Boston
Brigham and Women's Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
National Cancer Institute (NCI)
NIH